Andy Kabele

DDS | Oral and Maxillofacial Surgeon



  
  1836 South Ave, La Crosse
  Wisconsin, 54601-5429

  608-782-7300    Maps & Directions
Andy Kabele is a La Crosse, Wisconsin based Oral and Maxillofacial Surgeon who is specialized in Oral and Maxillofacial Surgery. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 1836 South Ave, La Crosse. Patients can reach him at 608-782-7300.
Andy Kabele deals with the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.
Complete Profile:
Andy Kabele speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Andy Kabele
Specialization: Oral and Maxillofacial Surgeon
Gender:Male
Credentials: DDS
Accepts Medicare Assignment:May Accept
Practice Address:1836 South Ave, La Crosse,
Wisconsin, 54601-5429
Phone:608-782-7300
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 8426106980
Enrollment ID: I20090511000534
NPI Number: 1932362092
NPI Enumeration Date: 08 Jul, 2008
NPI Last Update On: 08 Jul, 2008

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 1836 South Ave,
La Crosse, Wisconsin
Zip: 54601-5429
Phone Number: 608-782-7300
Patients can reach Andy Kabele at 1836 South Ave, La Crosse, Wisconsin or can call to book an appointment on 608-782-7300. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.

Comments/ Reviews: